Committee Seeks More Information On Long-Term Use Of Xifaxan For IBS-D
This article was originally published in The Pink Sheet Daily
Executive Summary
Success in a single course of treatment is not enough to identify patients for long-term intermittent treatment with the antibiotic, the Gastrointestinal Drugs Advisory Committee tells FDA Nov. 16